Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01029002 · ClinicalTrials.gov registry record · Phase 3
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
A Phase 3 study of Proteinuria and Chronic Renal Insufficiency, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 3
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT01029002: Completed Phase 3 study of Proteinuria and Chronic Renal Insufficiency, sponsored by Albert Einstein College of Medicine.
NCT01029002 is a Phase 3 study of Proteinuria and Chronic Renal Insufficiency that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 74 participants, below the 199-participant average among 10 other Proteinuria trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01029002, a Phase 3 study of Proteinuria and Chronic Renal Insufficiency, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized clinical trial to determine if vitamin D repletion in CKD (Chronic Kidney Disease) patients with low vitamin D levels will decrease proteinuria, a marker of kidney damage.
Primary Outcome
Urine albumin and creatinine were measured on spot urine specimens.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Vitamin D
Study Locations (1)
New York
- Montefiore medical center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2009-10 |
| Est. Completion | 2014-06 |
| Phase | Phase 3 |
What the finished NCT01029002 record still lists
NCT01029002 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 199-participant average among 10 other Proteinuria trials with a reported enrollment target (63% lower).
The record links to 2 conditions, with Proteinuria appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01029002 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01029002 about?
NCT01029002 is a clinical study titled "The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease". A randomized clinical trial to determine if vitamin D repletion in CKD (Chronic Kidney Disease) patients with low vitamin D levels will decrease proteinuria, a marker of kidney damage.
What is the current status of trial NCT01029002?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 74 participants. The study started on 2009-10. Estimated completion is 2014-06.
What conditions does trial NCT01029002 study?
This clinical trial studies the following conditions: Proteinuria, Chronic Renal Insufficiency.
What interventions are being tested in trial NCT01029002?
The interventions under investigation include: Placebo (OTHER), Vitamin D (DRUG).
Who is sponsoring clinical trial NCT01029002?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01029002 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Proteinuria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01029002's enrollment target sits among peer trials
74 5th of 10 higher than 6 of 10 other Proteinuria trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Proteinuria trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
RECRUITING · Phase 3
-
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
RECRUITING · Phase 3
-
Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
COMPLETED · Phase 3
-
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
RECRUITING · Phase 2
-
Proteinuria in Pre and Post Transplant
RECRUITING
-
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia